Categories Analysis, Technology
AI deployment, global expansion in focus as Salesforce gets ready for Q2 report
The second-quarter report is expected to come on Wednesday, August 28, after the closing bell
Salesforce, Inc. (NYSE: CRM), the customer relationship management platform that delivered profitable growth in recent years, experienced a demand slowdown in the early part of fiscal 2025. The mixed start to the year, with modest topline performance and strong earnings growth, indicates that the deployment of artificial intelligence features across the platform is yet to translate into revenues.
Salesforce’s share price reached an all-time high in early March, more than doubling since the beginning of 2023. But, the shares suffered a dip soon after the first-quarter earnings report, reversing the momentum, as investors were disappointed by the revenue miss. Earlier this year, the company declared its first-ever quarterly cash dividend of $0.40 per share, to be paid on July 25, 2024.
Estimates
Salesforce will be publishing second-quarter 2025 earnings on Wednesday, August 28, at 4:00 pm ET. The management predicts adjusted profit in the $2.34-2.36 per share range and revenues between $9.20 billion and $9.25 billion. The guidance is above Wall Street’s earnings projection of $2.10 per share and top-line estimate of $8.24 billion. In the second quarter of 2024, the company reported earnings of $2.12 per share on revenues of $8.60 billion.
The tech firm’s leadership recently issued cautious full-year subscription and support growth guidance to reflect delays in executing large projects by customers. Currently, its growth strategy is focused on multi-cloud deals, international expansion, and data/AI innovations across the platform. Einstein, the AI-enabled smart assistant system designed to enhance customer experience, is widely used by customers across industries. The company is also expanding its footprint in international markets, with important client wins in Latin America, the Middle East/Africa, and Asia Pacific.
Stable Profitability
For more than a decade, Salesforce has consistently met or exceeded Wall Street’s quarterly profit projections, including in the first quarter of 2025. First-quarter profit jumped 44% annually to $2.44 per share, excluding special items. That was driven by double-digit revenue growth across all operating segments, resulting in an 11% rise in total revenues to $9.13 billion. The top line, however, fell short of expectations. The management’s full-year revenue and earnings estimates are $37.7-38.0 billion and $9.86-9.94 per share, respectively.
Commenting on the company’s AI strategy, CEO Marc Benioff said in a recent statement, “Now, we’re working with thousands of customers to power generative AI use cases with our Einstein Copilot, our prompt builder, our Einstein Studio, all of which went live in the first quarter. And we’ve closed hundreds of copilot deals since this incredible technology has gone GA. And in just the last few months, we’re seeing Einstein Copilot develop higher levels of capability. We are absolutely delighted and cannot be more excited about the success that we’re seeing with our customers with this great new capability.”
Partnership
Last month, the company signed a strategic partnership with Workday for a new AI employee service to help employees work smarter and faster. Salesforce’s new Agentforce Platform and Einstein AI, in combination with the Workday platform, will enable enterprises to create and manage agents for employee service use cases.
CRM has mostly recovered from the post-earning selloff a few months ago and is currently trading above its 12-month average. On Monday, the stock opened higher and made modest gains in the early half of the session.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on